Qilu Pharmaceutical Co., Ltd.

This product is a semi-synthetic penicillin antibiotic. It has antibacterial effects on Pseudomonas aeruginosa, Escherichia coli, Klebsiella pneumoniae, Proteus, Enterobacter, Citrobacter, Serratia, Acinetobacter, and Gram-positive cocci sensitive to penicillin. It has a bactericidal effect in large doses. Its antibacterial activity against Escherichia coli, Enterobacter, Klebsiella pneumoniae, Citrobacter, Serratia, and Acinetobacter is stronger than carbenicillin and ampicillin; its antibacterial activity against indole-positive Proteus and Pseudomonas aeruginosa is stronger than carbenicillin and sulbenicillin; its antibacterial activity against Gram-positive bacteria such as Staphylococcus aureus is similar to that of carbenicillin, and its antibacterial activity against Streptococcus faecalis is superior to that of carbenicillin and sulbenicillin. It has good antibacterial effect on most anaerobic bacteria such as Bacteroides fragilis. In vitro tests of this product show that it is unstable to (lactamase produced by bacteria. This product has a significant synergistic effect when used in combination with aminoglycoside antibiotics such as gentamicin and kanamycin.

This product is a semi-synthetic penicillin antibiotic. It has antibacterial effects on Pseudomonas aeruginosa, Escherichia coli, Klebsiella pneumoniae, Proteus, Enterobacter, Citrobacter, Serratia, Acinetobacter, and Gram-positive cocci sensitive to penicillin. It has a bactericidal effect in large doses. Its antibacterial activity against Escherichia coli, Enterobacter, Klebsiella pneumoniae, Citrobacter, Serratia, and Acinetobacter is stronger than carbenicillin and ampicillin; its antibacterial activity against indole-positive Proteus and Pseudomonas aeruginosa is stronger than carbenicillin and sulbenicillin; its antibacterial activity against Gram-positive bacteria such as Staphylococcus aureus is similar to that of carbenicillin, and its antibacterial activity against Streptococcus faecalis is superior to that of carbenicillin and sulbenicillin. It has good antibacterial effect on most anaerobic bacteria such as Bacteroides fragilis. In vitro tests of this product show that it is unstable to (lactamase produced by bacteria. This product has a significant synergistic effect when used in combination with aminoglycoside antibiotics such as gentamicin and kanamycin.

Extract from the above information

It has an anti-inflammatory effect on experimental conjunctival edema in rats; it has an almost complete inhibitory effect on the increase in aqueous humor protein concentration after anterior chamber puncture or laser irradiation in rabbits; it has an inhibitory effect on the production of inflammatory mediators of the prostaglandin system through cyclooxygenase (invitro).

It is not possible to clearly extract a specific description of the pharmacological action from the above information